250 likes | 441 Vues
Noeplasia II Epidemiology of Cancer. Husni Maqboul, M.D. Epidemiology Of Cancer. Cancer: A significant health problem, second only to heart disease with regard to morbidity and mortality Responsible for 564,000 deaths in 1998 Accounted for 23 % of all deaths
E N D
Noeplasia IIEpidemiology of Cancer Husni Maqboul, M.D
Epidemiology Of Cancer • Cancer: A significant health problem, second only to heart disease with regard to morbidity and mortality • Responsible for 564,000 deaths in 1998 • Accounted for 23 % of all deaths • Residents of U.S.A. have a one in five chance of dying of cancer • Over 1,000,000 new cases each year (excluding 1 mln. cases of non-melanoma skin cancer ) • EVERY BODY HAS HIS CANCER, HE JUST HAS TO LIVE LONG ENOUGH TO GET IT
Cancer, Exogenous & endogenous factors • The only certain way of avoiding cancer is not to be born !!!!!
Environmental Carcinogens • Drugs: antineoplastic, immune suppressing etc.. • Organic chemicals: Insecticides, herbicides, aromatic hydrocarbons, etc.. • Cigarette Smoke • Ethanol • Heavy Metals • Sexually transmitted viruses: HTLV-I, Herpes simplex, Human papilloma virus • Radiation: Ultraviolet light
Age and Cancer • Cancer Mortality by Age for Males
Heredity and Cancer • Hereditary predisposition • Clustering of environmentally induced cancers in families. • Close relatives of cancer patients have three times greater risk of developing the same neoplasm. • Close relatives of patients with breast, colon, or endocrine cancers have greater than three times risk for developing the same neoplasm. • Increased cancer risk with inherited mutations of cancer suppressor genes such as Rb and p53.
Heredity and Cancer • Inherited Cancer Syndromes • Specific sites and tissue involved in each syndrome • Tumors often associated with specific marker phenotype ( benign tumors, café-au-lait spots ) • Incomplete penetrance and variable expressivity
Heredity and Cancer • Familial Cancers • Early age of onset • Tumors arise in two or more close relatives • Some times multiple and bilateral • No specific marker phenotype • ? Inherited or mutant genes e.g BRCA-1 & BRCA-2
Acquired Preneoplastic Syndromes • Proliferative lesions • Regenerative cell replication • Hyperplastic proliferation • Neoplastic - Villous and tubular adenomas • Dysplastic lesions • Clinically correlated • Atrophic gastritis • U.C and Crohn’s disease • Leukoplakia